Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |